Wang Y - Search Results

1

Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor.

Gong C, Zhang X, Shi M, Li F, Wang S, Wang Y, Wang Y, Wei W, Ma G. Gong C, et al. Among authors: wang y, wang s. Adv Sci (Weinh). 2021 Mar 16;8(10):2002787. doi: 10.1002/advs.202002787. eCollection 2021 May. Adv Sci (Weinh). 2021. PMID: 34026432 Free PMC article.

2

Targeting poly (ADP-ribose) polymerase partially contributes to bufalin-induced cell death in multiple myeloma cells.

Huang H, Cao Y, Wei W, Liu W, Lu SY, Chen YB, Wang Y, Yan H, Wu YL. Huang H, et al. Among authors: wang y. PLoS One. 2013 Jun 7;8(6):e66130. doi: 10.1371/journal.pone.0066130. Print 2013. PLoS One. 2013. PMID: 23762475 Free PMC article.

3

Exosomes as Actively Targeted Nanocarriers for Cancer Therapy.

Wang Y, Zhang Y, Cai G, Li Q. Wang Y, et al. Int J Nanomedicine. 2020 Jun 17;15:4257-4273. doi: 10.2147/IJN.S239548. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32606676 Free PMC article. Review.

4

Programmable Unlocking Nano-Matryoshka-CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response.

Yang J, Li Z, Shen M, Wang Y, Wang L, Li J, Yang W, Li J, Li H, Wang X, Wu Q, Gong C. Yang J, et al. Among authors: wang x, wang l, wang y. Adv Sci (Weinh). 2021 May 14;8(13):2100292. doi: 10.1002/advs.202100292. eCollection 2021 Jul. Adv Sci (Weinh). 2021. PMID: 34258164 Free PMC article.

5

Autophagy and Leukemia.

Zheng Z, Wang L, Cheng S, Wang Y, Zhao W. Zheng Z, et al. Among authors: wang l, wang y. Adv Exp Med Biol. 2020;1207:601-613. doi: 10.1007/978-981-15-4272-5_43. Adv Exp Med Biol. 2020. PMID: 32671778 Review.

6

[Immunotherapy for Lung Cancer: Mechanisms of Resistance and Response Strategy].

Yang Y, Yang L, Wang Y. Yang Y, et al. Among authors: wang y. Zhongguo Fei Ai Za Zhi. 2021 Feb 20;24(2):112-123. doi: 10.3779/j.issn.1009-3419.2021.101.02. Zhongguo Fei Ai Za Zhi. 2021. PMID: 33626853 Free PMC article. Review. Chinese.

7

Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network.

Zhang L, Zhao D, Wang Y, Zhang W, Zhang J, Fan J, Zhan Q, Chen J. Zhang L, et al. Among authors: wang y. Mol Carcinog. 2021 Feb;60(2):113-124. doi: 10.1002/mc.23273. Epub 2020 Dec 6. Mol Carcinog. 2021. PMID: 33283357

8

MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.

Xiang RF, Wang Y, Zhang N, Xu WB, Cao Y, Tong J, Li JM, Wu YL, Yan H. Xiang RF, et al. Among authors: wang y. Cell Death Dis. 2017 May 11;8(5):e2776. doi: 10.1038/cddis.2017.188. Cell Death Dis. 2017. PMID: 28492559 Free PMC article.

9

Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment.

Yang Y, Wang Y. Yang Y, et al. Among authors: wang y. Front Immunol. 2021 Apr 2;12:640369. doi: 10.3389/fimmu.2021.640369. eCollection 2021. Front Immunol. 2021. PMID: 33868269 Free PMC article. Review.

10

Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatment.

Zhao D, Chen J, Wang Y, Zhang L, Zhang J, Zhang W, Fan J, Li J, Zhan Q. Zhao D, et al. Among authors: wang y. Mol Carcinog. 2021 Jul;60(7):481-496. doi: 10.1002/mc.23306. Epub 2021 May 21. Mol Carcinog. 2021. PMID: 34018249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295,126 results

Search Page

Filters